Literature DB >> 3290501

Update in cancer chemotherapy: genitourinary tract cancer, Part 4: Testicular cancer.

J C Wright.   

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of genitourinary tract cancer is described in this multi-part series: included are cancers of the kidney, bladder, prostate, testicle, ovary, uterus, vulva, and gestational trophoblastic neoplasms. Part 4 is a review of treatments for cancer of the testicles.Testicular cancer is highly curable and responds well to both surgery and chemotherapy. Patients with stage I and stage II nonseminomatous germ-cell tumors may be cured by surgery alone or in combination with chemotherapy. In patients with pathologic stage II disease, the use of adjuvant chemotherapy with two courses of platinum-based combination drugs has been successful in preventing relapse. Further refinements in management and research could banish the problem of testicular cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290501      PMCID: PMC2625752     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

1.  The chemotherapy of urologic cancer.

Authors:  S K Carter; T H Wasserman
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  LATE RESULTS OF SARCOLYSIN THERAPY IN TUMOURS OF THE TESTES.

Authors:  L I CHEBOTAREVA
Journal:  Acta Unio Int Contra Cancrum       Date:  1964

3.  Diamminodichloroplatinum in the chemotherapy of testicular tumors.

Authors:  D J Higby; H J Wallace; D Albert; J F Holland
Journal:  J Urol       Date:  1974-07       Impact factor: 7.450

4.  Vinblastine in the management of testicular cancer.

Authors:  M L Samuels; C D Howe
Journal:  Cancer       Date:  1970-05       Impact factor: 6.860

5.  Mithramycin in metastatic urogenital cancer.

Authors:  A R Mackenzie; N Duruman; W F Whitmore
Journal:  J Urol       Date:  1967-07       Impact factor: 7.450

6.  A chemotherapeutic approach to advanced testicular carcinoma.

Authors:  J K Wyatt; L N McAninch
Journal:  Can J Surg       Date:  1967-10       Impact factor: 2.089

7.  Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin.

Authors:  R E Wittes; A Yagoda; O Silvay; G B Magill; W Whitmore; I H Krakoff; R B Golbey
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

8.  Bleomycin combination chemotherapy in the management of testicular neoplasia.

Authors:  M L Samuels; P Y Holoye; D E Johnson
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

9.  Germ cell tumors (II): VAB II in metastatic testicular cancer.

Authors:  E Cheng; E Cvitkovic; R E Wittes; R B Golbey
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.